Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc. company information, Employees & Contact Information

Explore related pages

Alpine Immune Sciences, Inc. email format Alpine Immune Sciences, Inc. management contacts

Related company profiles:

Alpine Immune Sciences is now part of Vertex Pharmaceuticals. Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. For more information about Vertex, please visit us at https://www.vrtx.com/. Follow Vertex on LinkedIn for future updates at https://www.linkedin.com/company/vertex-pharmaceuticals/.

Company Details

Employees
43
Founded
-
Address
188 E Blaine St,
Phone
(206)441-5062
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
alpineimmunesciences.com
Keywords
Provider jobs.
HQ
Seattle, Washington
Competitors
Seagen, Adaptive Biotechnologies Corp., Omeros Corporation, Sonoma Biotherapeutics, Inc., Morphic Therapeutic, CymaBay Therapeutics, Shape Therapeutics Inc., Umoja Biopharma, Sana Biotechnology, Inc., Vertex Pharmaceuticals.
Looking for a particular Alpine Immune Sciences, Inc. employee's phone or email?

Alpine Immune Sciences, Inc. Questions

News

Pathways to Success: Key Takeaways from Alpine Immune Sciences CEO Mitch Gold - fenwick.com

Pathways to Success: Key Takeaways from Alpine Immune Sciences CEO Mitch Gold fenwick.com

Alpine Immune Sciences to Report Fourth Quarter and Full Year 2023 Financial Results - Business Wire

Alpine Immune Sciences to Report Fourth Quarter and Full Year 2023 Financial Results Business Wire

Truveta and Alpine Immune Sciences Announce Strategic Partnership to Access Truveta’s Community to Accelerate Recruitment to Povetacicept Clinical Trials - Yahoo Finance

Truveta and Alpine Immune Sciences Announce Strategic Partnership to Access Truveta’s Community to Accelerate Recruitment to Povetacicept Clinical Trials Yahoo Finance

Vertex Enters Into Agreement to Acquire Alpine Immune Sciences - Stock Titan

Vertex Enters Into Agreement to Acquire Alpine Immune Sciences Stock Titan

Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion - WSJ - The Wall Street Journal

Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion - WSJ The Wall Street Journal

Alpine Immune Sciences Appoints Wolfgang Dummer, M.D., Ph.D., As Chief Medical Officer - citybiz

Alpine Immune Sciences Appoints Wolfgang Dummer, M.D., Ph.D., As Chief Medical Officer citybiz

Alpine Immune Sciences to Participate in Two Upcoming Healthcare Conferences - Business Wire

Alpine Immune Sciences to Participate in Two Upcoming Healthcare Conferences Business Wire

Alpine Immune Sciences to Participate in Fireside Chat at the Piper Sandler 32nd Annual Virtual Healthcare Conference - Stock Titan

Alpine Immune Sciences to Participate in Fireside Chat at the Piper Sandler 32nd Annual Virtual Healthcare Conference Stock Titan

Alpine Immune Sciences Presents Initial Clinical Data on Povetacicept in Autoimmune Glomerulonephritis in a Late-Breaking Poster Session at the American Society of Nephrology Kidney Week 2023 - Business Wire

Alpine Immune Sciences Presents Initial Clinical Data on Povetacicept in Autoimmune Glomerulonephritis in a Late-Breaking Poster Session at the American Society of Nephrology Kidney Week 2023 Business Wire

Alpine Immune Sciences Presents New Translational Data on Povetacicept at the European Lupus Meeting 2024 - Business Wire

Alpine Immune Sciences Presents New Translational Data on Povetacicept at the European Lupus Meeting 2024 Business Wire

Alpine Immune Sciences to Present Updated Clinical Data for Povetacicept in IgA Nephropathy at the World Congress of Nephrology 2024 - Business Wire

Alpine Immune Sciences to Present Updated Clinical Data for Povetacicept in IgA Nephropathy at the World Congress of Nephrology 2024 Business Wire

Alpine Immune Sciences Provides Corporate Update and Full Year 2023 Financial Results - Business Wire

Alpine Immune Sciences Provides Corporate Update and Full Year 2023 Financial Results Business Wire

Alpine Immune Sciences Shares Updated Clinical Data from Povetacicept in IgA Nephropathy - Business Wire

Alpine Immune Sciences Shares Updated Clinical Data from Povetacicept in IgA Nephropathy Business Wire

Alpine Immune Sciences Announces Pricing of $150 Million Public Offering - Business Wire

Alpine Immune Sciences Announces Pricing of $150 Million Public Offering Business Wire

Alpine Immune Sciences Announces Amendment of Acazicolcept Option and License Agreement with AbbVie - Business Wire

Alpine Immune Sciences Announces Amendment of Acazicolcept Option and License Agreement with AbbVie Business Wire

Alpine Immune Sciences and Horizon Therapeutics plc Announce Exclusive License and Collaboration Agreement to Develop Novel Protein-Based Therapies for Autoimmune and Inflammatory Diseases - Business Wire

Alpine Immune Sciences and Horizon Therapeutics plc Announce Exclusive License and Collaboration Agreement to Develop Novel Protein-Based Therapies for Autoimmune and Inflammatory Diseases Business Wire

Vertex to buy Alpine Immune Sciences for $4.9 billion - statnews.com

Vertex to buy Alpine Immune Sciences for $4.9 billion statnews.com

Vertex pays $4.9 billion to hike Alpine’s immunology trail - Fierce Biotech

Vertex pays $4.9 billion to hike Alpine’s immunology trail Fierce Biotech

Vertex will buy Alpine Immune Sciences for $4.9B in another big Seattle biotech deal - GeekWire

Vertex will buy Alpine Immune Sciences for $4.9B in another big Seattle biotech deal GeekWire

Vertex to Acquire Alpine Immune Sciences for $4.9B, Broadening Kidney Drug Pipeline - Genetic Engineering and Biotechnology News

Vertex to Acquire Alpine Immune Sciences for $4.9B, Broadening Kidney Drug Pipeline Genetic Engineering and Biotechnology News

FDA Grants ALPN-101 Orphan Drug Designations in GVHD - OncLive

FDA Grants ALPN-101 Orphan Drug Designations in GVHD OncLive

What Vertex Pharmaceuticals Is Getting With Acquisition Of Alpine Immune Sciences (VRTX) - Seeking Alpha

What Vertex Pharmaceuticals Is Getting With Acquisition Of Alpine Immune Sciences (VRTX) Seeking Alpha

News - FinancialContent

News FinancialContent

Companies like Alpine Immune Sciences, Inc.

Shape Therapeutics Inc. logo - Similar company to Alpine Immune Sciences, Inc.

Shape Therapeutics Inc.

79
Vertex Pharmaceuticals logo - Similar company to Alpine Immune Sciences, Inc.

Vertex Pharmaceuticals

6.09K
Sonoma Biotherapeutics, Inc. logo - Similar company to Alpine Immune Sciences, Inc.

Sonoma Biotherapeuti...

117
Sana Biotechnology, Inc. logo - Similar company to Alpine Immune Sciences, Inc.

Sana Biotechnology, ...

256
Umoja Biopharma logo - Similar company to Alpine Immune Sciences, Inc.

Umoja Biopharma

201
Adaptive Biotechnologies Corp. logo - Similar company to Alpine Immune Sciences, Inc.

Adaptive Biotechnolo...

646
Morphic Therapeutic logo - Similar company to Alpine Immune Sciences, Inc.

Morphic Therapeutic

56
Omeros Corporation logo - Similar company to Alpine Immune Sciences, Inc.

Omeros Corporation

227
CymaBay Therapeutics logo - Similar company to Alpine Immune Sciences, Inc.

Cymabay Therapeutics

35
Seagen logo - Similar company to Alpine Immune Sciences, Inc.

Seagen

928

Top Alpine Immune Sciences, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant